| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Cutaneous solution spray |
Is a |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| karbolfuksinlösning för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Clotrimazole 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Efinaconazole 100 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Hydrogen peroxide 300 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine diacetate 200 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely phenol 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely phenol 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| klindamycinfosfat 10 milligram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Aminolevulinic acid hydrochloride 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Diclofenac sodium 15 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Podophyllotoxin 5 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| cetrimid 5 milligram/milliliter och klorhexidinglukonat (som klorhexidin) 500 mikrogram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Methylrosanilinium chloride 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Potassium permanganate 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Silver nitrate 250 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Silver nitrate 500 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| klorhexidinglukonat 0,5 % i 70 % IMS, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| klorhexidinglukonat 0,5 % / natriumnitrit 0,1 % i 70 % IMS, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| lidokainhydroklorid 2 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| ciklopiroxolamin 8 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Haloprogin 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| fluorouracil 1 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Aluminium chloride 250 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Fluorouracil 20 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| fluorouracil 5 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| klorhexidinglukonat 1 % + etylalkohol 61 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| natriumhypoklorit 0,5 %, lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| jod 0,7 %/isopropanol 74 vikt per vikt, lösning för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Aluminium chloride 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cetrimide 400 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 50 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| kokain 10 %, viskös kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| kokain 4 %, viskös kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Povidone iodine 40 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| natriumhypoklorit 8 %, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Sodium hypochlorite 10 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| koltjära 40 %, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| rekombinant trombin 20 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| bovint trombin 20 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| bovint trombin 5 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| rekombinant trombin 5 000 IE, pulver till kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|
| Tioconazole 283 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Benzocaine 200 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Solution for iontophoresis |
Is a |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Cocaine hydrochloride 40 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Triclosan 20 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Coal tar 100 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Salicylic acid 170 mg/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| Tretinoin 500 microgram/mL cutaneous solution |
Has manufactured dose form |
True |
Cutaneous solution |
Inferred relationship |
Some |
|
| amorolfinhydroklorid 50 milligram/milliliter, kutan lösning |
Has manufactured dose form |
False |
Cutaneous solution |
Inferred relationship |
Some |
|